Cargando…
Clinical Approaches for Mitochondrial Diseases
Mitochondria are subcontractors dedicated to energy production within cells. In human mitochondria, almost all mitochondrial proteins originate from the nucleus, except for 13 subunit proteins that make up the crucial system required to perform ‘oxidative phosphorylation (OX PHOS)’, which are expres...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605124/ https://www.ncbi.nlm.nih.gov/pubmed/37887337 http://dx.doi.org/10.3390/cells12202494 |
_version_ | 1785126998378545152 |
---|---|
author | Hong, Seongho Kim, Sanghun Kim, Kyoungmi Lee, Hyunji |
author_facet | Hong, Seongho Kim, Sanghun Kim, Kyoungmi Lee, Hyunji |
author_sort | Hong, Seongho |
collection | PubMed |
description | Mitochondria are subcontractors dedicated to energy production within cells. In human mitochondria, almost all mitochondrial proteins originate from the nucleus, except for 13 subunit proteins that make up the crucial system required to perform ‘oxidative phosphorylation (OX PHOS)’, which are expressed by the mitochondria’s self-contained DNA. Mitochondrial DNA (mtDNA) also encodes 2 rRNA and 22 tRNA species. Mitochondrial DNA replicates almost autonomously, independent of the nucleus, and its heredity follows a non-Mendelian pattern, exclusively passing from mother to children. Numerous studies have identified mtDNA mutation-related genetic diseases. The consequences of various types of mtDNA mutations, including insertions, deletions, and single base-pair mutations, are studied to reveal their relationship to mitochondrial diseases. Most mitochondrial diseases exhibit fatal symptoms, leading to ongoing therapeutic research with diverse approaches such as stimulating the defective OXPHOS system, mitochondrial replacement, and allotropic expression of defective enzymes. This review provides detailed information on two topics: (1) mitochondrial diseases caused by mtDNA mutations, and (2) the mechanisms of current treatments for mitochondrial diseases and clinical trials. |
format | Online Article Text |
id | pubmed-10605124 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106051242023-10-28 Clinical Approaches for Mitochondrial Diseases Hong, Seongho Kim, Sanghun Kim, Kyoungmi Lee, Hyunji Cells Review Mitochondria are subcontractors dedicated to energy production within cells. In human mitochondria, almost all mitochondrial proteins originate from the nucleus, except for 13 subunit proteins that make up the crucial system required to perform ‘oxidative phosphorylation (OX PHOS)’, which are expressed by the mitochondria’s self-contained DNA. Mitochondrial DNA (mtDNA) also encodes 2 rRNA and 22 tRNA species. Mitochondrial DNA replicates almost autonomously, independent of the nucleus, and its heredity follows a non-Mendelian pattern, exclusively passing from mother to children. Numerous studies have identified mtDNA mutation-related genetic diseases. The consequences of various types of mtDNA mutations, including insertions, deletions, and single base-pair mutations, are studied to reveal their relationship to mitochondrial diseases. Most mitochondrial diseases exhibit fatal symptoms, leading to ongoing therapeutic research with diverse approaches such as stimulating the defective OXPHOS system, mitochondrial replacement, and allotropic expression of defective enzymes. This review provides detailed information on two topics: (1) mitochondrial diseases caused by mtDNA mutations, and (2) the mechanisms of current treatments for mitochondrial diseases and clinical trials. MDPI 2023-10-20 /pmc/articles/PMC10605124/ /pubmed/37887337 http://dx.doi.org/10.3390/cells12202494 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Hong, Seongho Kim, Sanghun Kim, Kyoungmi Lee, Hyunji Clinical Approaches for Mitochondrial Diseases |
title | Clinical Approaches for Mitochondrial Diseases |
title_full | Clinical Approaches for Mitochondrial Diseases |
title_fullStr | Clinical Approaches for Mitochondrial Diseases |
title_full_unstemmed | Clinical Approaches for Mitochondrial Diseases |
title_short | Clinical Approaches for Mitochondrial Diseases |
title_sort | clinical approaches for mitochondrial diseases |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605124/ https://www.ncbi.nlm.nih.gov/pubmed/37887337 http://dx.doi.org/10.3390/cells12202494 |
work_keys_str_mv | AT hongseongho clinicalapproachesformitochondrialdiseases AT kimsanghun clinicalapproachesformitochondrialdiseases AT kimkyoungmi clinicalapproachesformitochondrialdiseases AT leehyunji clinicalapproachesformitochondrialdiseases |